Ballooning Potential for Hemp Derived CBD Based Products Generating Notable Revenue Opportunities

Palm Beach, FL – (October 11, 2018) – Cannabidiol (CBD), one of the more than 100 chemicals found in cannabis, is emerging as a popular wellness ingredient amongst other applications and uses.  The hemp-derived CBD market is steadily increasing its foothold within the medical community as research and development for alternative treatment methods propels CBD-based solutions to new heights. One of the appealing factors is the natural composition of CBD-based solutions in a time when consumers are wary about what they are ingesting when it comes to medicine. As a result, the CBD industry is thriving in North America and Greenwave Advisors anticipates that the CBD industry could reach $3 billion by 2021 and eventually well over $200 billion in the U.S., if the so-called Farm Bill legalizing hemp as a crop passes.  Active cannabis companies in the markets this week include Earth Science Tech, Inc. (OTC:ETST), India Globalization Capital, Inc. (NYSE:IGC), Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON), Aphria Inc. (TSX:APH.TO) (OTC:APHQF), New Age Beverages Corporation (NASDAQ:NBEV).


Earth Science Tech, Inc. (OTCQB: ETST) BREAKING NEWS:  Earth Science Tech , an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces that it has entered talks for a potential exclusive business/supply agreement with an organic CBD grower and processor.


ETST is interested in utilizing the grower and processor’s outdoor organic industrial hemp plants, extraction, mixing, bottling and packaging capabilities on an exclusive basis. ETST believes an ex-clusive development, licensing, and supply agreement with the grower and processor would enable a consistent, marketable industrial hemp source, potentially increasing revenues for both ETST and grower.


ETST president, director, and Chairman Nickolas S. Tabraue stated, “This is a huge opportunity for Earth Science Tech and one that has the potential to dramatically change our dynamics. If complet-ed, this exclusive agreement would enable us to fulfill our many industrial hemp raw bulk inquires, further expand our revenues, and lower our cost of finished goods, all while offering optimal full Spectrum Cannabinoids quality as well as unique cannabinoid products through the grower and pro-cessor’s innovative technologies. I plan on sharing more updates as we progress to a final agree-ment.”    Read this and more news for ETST at

Other recent developments in the cannabis industry include:


India Globalization Capital Inc. (NYSE:IGC) closed up 5.81% on Wednesday afternoon with a volume north of 15.6 million by the market close. On Tuesday, the company announced it has filed a provisional method and composition patent application (IGC-509) with the U.S. Patent and Trademark Office (USPTO) for the treatment of fatigue and energy restoration. The filing is for a provisional patent and no assurance can be given as to whether or when a registered patent may be granted by the USPTO in the future. This patent filing made on October 4, 2018, is one of a series of steps in the Company’s development and commercialization plan to support the creation of a branded, hemp/CBD sugar-free energy drink, which was previously disclosed by the Company on September 25, 2018. The patent filing allows the Company to openly discuss the CBD energy drink formulation with processors in the United States, Canada, and other countries where medical cannabis, or hemp and hemp-derived products are legal. The Company maintains a corporate compliance policy for all products under development with respect to regulations associated with each individual market.


Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON)  and Aleafia Health (ALEF.TO) recently announced the commencement of a joint medical cannabis study to improve the management and treatment of insomnia and daytime sleepiness. The study is funded in part by Peace Naturals Project Inc., a licensed producer of medical cannabis that is wholly owned by Cronos Group. The study will be led by physicians practicing within the Canabo Medical Clinic network, which is wholly owned by Aleafia. According to a July 2017 report from the Canadian Centre on Substance Use and Addiction, entitled Drug Summary: Prescription Sedatives, 11.4 per cent of adults aged 25 and older had used a prescription sedative in the past year. The study will aim to assist in the treatment of insomnia and the development of non-addictive, natural sleep aids.


Aphria Inc. (TSX:APH.TO) (OTCQB:APHQF) recently unveiled its comprehensive portfolio of adult-use brands that will be available for sale in the adult-use market. Backed by more than a year and a half of extensive qualitative and quantitative research, including focus groups and influencer consultations, the Company has developed a portfolio of brands designed to meet the needs of specific consumer segments. The brands feature a range of price points and offer a variety of product formats and consumption options tailored to consumer preferences. “When we embarked on our journey to develop our adult-use brands, we were committed to truly understanding what cannabis users would look like after legalization,” said Megan McCrae , Vice President of Marketing at Aphria. “We undertook extensive research to understand each segment of the market and build a broad portfolio of brands that would speak to each of those varied and diverse groups. This consumer-centric approach is the cornerstone of every one of our thoughtfully-created brands and will continue to drive our ongoing product development and brand positioning.”


New Age Beverages Corporation (NASDAQ:NBEV) closed Wednesday up 5.06% with more than 19.6 million shares traded by the market close. The company also announced the debut of its portfolio of CBD-Infused beverages from its Health Sciences Division. Some of the country’s largest distributors and retailers also attended New Age’s CBD launch event where they tasted the company’s range of CBD-infused sparkling waters and CBD-infused relaxation teas, and received brand and product overviews, pricing, and pre-order information. Michael Cunningham, senior vice president of sales for New Age commented, “The demand and interest for these products is unlike I have ever seen in my career. Customers loved the taste of New Age’s CBD-infused products and many of them committed to bring in the products for sale.


DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates and, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks..  For current services performed FNM has been compensated forty six hundred dollars for news coverage of the current press releases issued by Earth Science Tech, Inc. by the company.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.


This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Contact Information:

Media Contact email: – +1(561)325-8757